NASDAQ: VYGR
Voyager Therapeutics Inc Earnings Dates, Reports, Calls

Voyager Therapeutics earnings were $25.9M for the trailing 12 months ending Sep 30, 2024, with -48.1% growth year over year. The latest VYGR earnings report on Sep 30, 2024 announced Q3 2024 earnings of -$9.0M, down 10.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, VYGR reported annual earnings of $132.3M, with -385.1% growth. The next VYGR earnings date is Feb 26, 2025.

VYGR past earnings growth

How has VYGR's earnings growth performed historically?

Company
-48.12%
Industry
21.69%
Market
47.91%
VYGR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
VYGR's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

VYGR earnings history

Current Revenue
$163.8M
Current Earnings
$25.9M
Current Profit Margin
15.8%

VYGR Return on Equity

Current Company
8.3%
Current Industry
19.9%
Current Market
35%
VYGR's Return on Equity (8.3%)... subscribe to Premium to read more.
High Return on Equity Performance

VYGR Return on Assets

Current Company
6.2%
Current Industry
1.3%
VYGR is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VYGR announces earnings.

VYGR Return on Capital Employed

Current Company
3.94%
Current Industry
14.3%
VYGR has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VYGR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VYGR$20.12M$25.88M-10.39%$0.69
IMMP-$28.46M-$28.48MN/A-$0.24
QSI-$83.47M-$89.93MN/A-$0.64
XOMA-$20.03M-$34.07MN/A-$3.44
NMRA-$289.29M-$293.70MN/A-$1.20

VYGR earnings dates

Next earnings date
Feb 26, 2025

Voyager Therapeutics Earnings Reports & History FAQ

What were Voyager Therapeutics's earnings last quarter?

On VYGR's earnings call on Invalid Date, Voyager Therapeutics (NASDAQ: VYGR) reported Q3 2024 earnings per share (EPS) of -$0.16, up 72.88% year over year. Total VYGR earnings for the quarter were -$9.04 million. In the same quarter last year, Voyager Therapeutics's earnings per share (EPS) was -$0.59.

If you're new to stock investing, here's how to buy Voyager Therapeutics stock.

When does Voyager Therapeutics report earnings?

The next VYGR earnings call is Invalid Date. Add VYGR to your watchlist to be reminded of Voyager Therapeutics's next earnings date.

What was VYGR's earnings growth in the past year?

As of Voyager Therapeutics's earnings date in Invalid Date, Voyager Therapeutics's earnings has grown -48.12% year over year. This is 69.81 percentage points lower than the US Biotechnology industry earnings growth rate of 21.69%. VYGR earnings in the past year totalled $25.88 million.

Is Voyager Therapeutics profitable or losing money?

As of the last Voyager Therapeutics earnings report, Voyager Therapeutics is currently profitable. Voyager Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $25.88 million, a 50.52% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.